The 5W1H in antiplatelet monotherapy after percutaneous coronary intervention: what, who, where, when, why, and how?-MedSci.cn

The 5W1H in antiplatelet monotherapy after percutaneous coronary intervention: what, who, where, when, why, and how?

Baber, U

Baber, U (通讯作者)，Univ Oklahoma, Hlth Sci Ctr, 800 Stanton L Young Blvd,Suite 5400, Oklahoma City, OK 73102 USA.

REVISTA ESPANOLA DE CARDIOLOGIA, 2022; 75 (2): 115

科室
- - 订阅+
  - 更多科室
工具
服务